Cancer 360, the cancer app on the Palantir-run Federated Data Platform (FDP), is used by five or six NHS trusts, the Register reported. Its November 13, 2026 report cites official figures.
NHS England said in June 2026 that five trusts were using the app as of March, with two listed as benefiting, the Register said. Data released in October put the count at six trusts as of June, with five benefiting. That data did not name the trusts and has since been removed from NHS England's website.
Last year NHS England said the app served 46 registered teams and 239 active users, and processed 52,000 patients, the Register reported. In June 2025 NHS England said Cancer 360 "drastically cut down diagnosis times." It cited a pilot at Chelsea and Westminster NHS Foundation Trust, where the share of patients diagnosed within 28 days rose from 72 percent to 85 percent.
A June Freedom of Information (FoI) reply from NHS England listed six trusts with app logins over 12 months, the Register said. Chelsea and Westminster and Royal United Hospitals Bath, both cited as successful pilots, showed zero unique users. The Register said it asked NHS England and both trusts to explain.
In separate reporting, the Guardian said NHS England insisted nearly 140 trusts "have now reported benefits from the wide range of tools available on the platform." That followed disputes over NHS England's count of trusts on the platform. A Palantir spokesperson told the Guardian its software is "helping to deliver better care."
The Register said the government is deciding whether to continue the contract "beyond February 2027." A House of Commons Library briefing says the decision is due by December 2026, with the initial term ending in March 2027. The Register and the Financial Times have reported that ministers are set to renew it and run a parallel procurement.
Why it matters: In Foundry News's view, platform-wide adoption and single-app counts measure different things. The Library puts platform adoption at 142 of 202 trusts in live use as of August 2026. Ahead of the extension decision, the figures to watch are named, app-level counts from NHS England.
